Star Combo Pharma Limited

ASX:S66 Stock Report

Market Cap: AU$15.5m

Star Combo Pharma Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Su Zhang

Chief executive officer

AU$196.3k

Total compensation

CEO salary percentage86.6%
CEO tenure6.2yrs
CEO ownership8.5%
Management average tenureno data
Board average tenure6.1yrs

Recent management updates

Should Shareholders Have Second Thoughts About A Pay Rise For Star Combo Pharma Limited's (ASX:S66) CEO This Year?

Nov 21
Should Shareholders Have Second Thoughts About A Pay Rise For Star Combo Pharma Limited's (ASX:S66) CEO This Year?

Recent updates

Star Combo Pharma Limited's (ASX:S66) Shares May Have Run Too Fast Too Soon

Mar 20
Star Combo Pharma Limited's (ASX:S66) Shares May Have Run Too Fast Too Soon

Should Shareholders Have Second Thoughts About A Pay Rise For Star Combo Pharma Limited's (ASX:S66) CEO This Year?

Nov 21
Should Shareholders Have Second Thoughts About A Pay Rise For Star Combo Pharma Limited's (ASX:S66) CEO This Year?

Star Combo Pharma's (ASX:S66) Robust Earnings Might Be Weaker Than You Think

Mar 02
Star Combo Pharma's (ASX:S66) Robust Earnings Might Be Weaker Than You Think

Rock star Growth Puts Star Combo Pharma (ASX:S66) In A Position To Use Debt

Dec 24
Rock star Growth Puts Star Combo Pharma (ASX:S66) In A Position To Use Debt

CEO Compensation Analysis

How has Su Zhang's remuneration changed compared to Star Combo Pharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

AU$485k

Sep 30 2023n/an/a

-AU$2m

Jun 30 2023AU$196kAU$170k

-AU$4m

Mar 31 2023n/an/a

-AU$5m

Dec 31 2022n/an/a

-AU$5m

Sep 30 2022n/an/a

-AU$3m

Jun 30 2022AU$194kAU$172k

-AU$696k

Mar 31 2022n/an/a

-AU$5m

Dec 31 2021n/an/a

-AU$8m

Sep 30 2021n/an/a

-AU$8m

Jun 30 2021AU$182kAU$163k

-AU$8m

Mar 31 2021n/an/a

-AU$3m

Dec 31 2020n/an/a

AU$1m

Sep 30 2020n/an/a

AU$533k

Jun 30 2020AU$169kAU$153k

-AU$349k

Mar 31 2020n/an/a

-AU$990k

Dec 31 2019n/an/a

-AU$2m

Sep 30 2019n/an/a

-AU$2m

Jun 30 2019AU$164kAU$150k

-AU$2m

Mar 31 2019n/an/a

-AU$2m

Dec 31 2018n/an/a

-AU$3m

Sep 30 2018n/an/a

-AU$2m

Jun 30 2018AU$93kAU$85k

-AU$2m

Jun 30 2017AU$66kAU$60k

AU$2m

Compensation vs Market: Su's total compensation ($USD128.35K) is below average for companies of similar size in the Australian market ($USD292.50K).

Compensation vs Earnings: Su's compensation has been consistent with company performance over the past year.


CEO

Su Zhang

6.2yrs

Tenure

AU$196,318

Compensation

Ms. Su Zhang, MBA, GradCertComm, BPharm serves as Chief Executive Officer at Star Combo Pharma Ltd since November 2018 and serves as its Executive Director since 2018. She served as Director at Star Combo...


Board Members

NamePositionTenureCompensationOwnership
Su Zhang
CEO & Executive Director6.2yrsAU$196.32k8.48%
A$ 1.3m
JinXing Zhang
Founder7.3yrsAU$198.93k28.25%
A$ 4.4m
Richard Allely
Independent Non-Executive Chairman6.1yrsAU$100.91kno data
Wei Han
Non Executive Director3.8yrsno datano data
Jialong Ding
Non Executive Director3.8yrsno datano data

6.1yrs

Average Tenure

Experienced Board: S66's board of directors are considered experienced (6.1 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.